Literature DB >> 6023769

Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

H S Seltzer, E W Allen, A L Herron, M T Brennan.   

Abstract

Insulin secretory responses to paired intravenous and oral glucose loads were determined in 38 nonobese individuals classified as normal (nondiabetic) subjects, "mild" diabetics (fasting blood glucose below 105 mg per 100 ml), or "moderate" diabetics (fasting glucose below 192 mg per 100 ml). Studies were also performed in 29 obese persons who were similarly grouped. The intravenous load was given to assess the alacrity of hormonal release after glycemic stimulus, and the oral glucose to determine how the speed of initial insulinogenesis modifies the disposition of ingested carbohydrate. In the nonobese group, normal subjects responded to massive hyperglycemia after rapid injection of glucose with immediate and maximal outpouring of insulin, in contrast to a desultory insulinogenic response in patients with mild diabetes, and no initial response at all in moderate diabetics. During oral glucose tolerance tests, the much faster clearance of blood sugar in nondiabetic subjects was actually associated with lower absolute insulin output than was found in mildly diabetic patients, since the latter exhibited delayed hyperinsulinemia in concert with prolonged hyperglycemia. Moderate diabetics never showed excessive insulin release despite even greater hyperglycemia. An empirical "insulinogenic index," the ratio relating enhancement of circulating insulin to magnitude of corresponding glycemic stimulus, was used to compare the secretory capacities of respective groups. Despite the higher absolute hormonal output after oral glucose in mild diabetics, the index revealed that insulin release in normal subjects was proportionally more than twice as great. This relatively greater normal secretory response declared itself shortly after the administration of glucose by either route, and was maintained throughout both tests. In the 29 obese individuals, differences among groups were essentially the same as in persons of normal weight. Obese nondiabetics did show much larger absolute insulinogenic responses during both tests than did nonobese controls. Since corresponding glucose tolerance curves were also higher, the mean insulinogenic indexes for obese subjects were not statistically greater. Moreover, when comparable glucose curves of obese and nonobese controls

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023769      PMCID: PMC297053          DOI: 10.1172/JCI105534

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  AN INTESTINAL HORMONE AFFECTING GLUCOSE DISPOSAL IN MAN.

Authors:  J DUPRE
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  EXHAUSTION OF INSULOGENIC RESERVE IN MATURITY-ONSET DIABETIC PATIENTS DURING PROLONGED AND CONTINUOUS HYPERGLYCEMIC STRESS.

Authors:  H S SELTZER; V L HARRIS
Journal:  Diabetes       Date:  1964 Jan-Feb       Impact factor: 9.461

3.  FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS.

Authors:  H S SELTZER; E W ALLEN; M T BRENNAN
Journal:  Diabetes       Date:  1965-07       Impact factor: 9.461

4.  Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.

Authors:  H S SELTZER
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

5.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

6.  Plasma insulin activity after glucose: an index of insulogenic reserve in normal and diabetic man.

Authors:  H S SELTZER; W L SMITH
Journal:  Diabetes       Date:  1959 Nov-Dec       Impact factor: 9.461

7.  Effect of secretin on insulin secretion.

Authors:  R H Unger; H Ketterer; A Eisentraut; J Dupré
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

8.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

9.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

10.  Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man.

Authors:  J H Karam; S G Grasso; L C Wegienka; G M Grodsky; P H Forsham
Journal:  Diabetes       Date:  1966-08       Impact factor: 9.461

View more
  257 in total

1.  [Glucose tolerance and insulin secretion in oral and intravenous glucose load after intraabdominal operation (author's transl)].

Authors:  R Bittner; H G Beger; R Roscher; E Kraas
Journal:  Langenbecks Arch Chir       Date:  1975

2.  Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part I-Effect of vagotomy on response to oral glucose.

Authors:  C S Humphrey; J R Dykes; D Johnston
Journal:  Br Med J       Date:  1975-04-19

3.  [Diurnal variation of glucose tolerance and insulin secretion in man (author's transl)].

Authors:  W Grabner; F Matzkies; H Prestele; A Rose; U Daniel; J Phillip; K Fischer
Journal:  Klin Wochenschr       Date:  1975-08-15

4.  Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy.

Authors:  J Miholic; H J Meyer; J Kotzerke; J Balks; H Aebert; J Jähne; A Weimann; R Pichlmayr
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

5.  Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis.

Authors:  Hiroyuki Inoue; Yoko Tamaki; Yushi Kashihara; Shota Muraki; Makoto Kakara; Takeshi Hirota; Ichiro Ieiri
Journal:  Br J Clin Pharmacol       Date:  2018-12-06       Impact factor: 4.335

6.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

Authors:  A Junod; A E Lambert; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

7.  Correction of diabetic pattern of insulin release from islets of the spiny mouse (Acomys cahirinus) by glucose priming in vitro.

Authors:  R Nesher; E Abramovitch; E Cerasi
Journal:  Diabetologia       Date:  1985-04       Impact factor: 10.122

8.  Effects of Two-Week Sleep Extension on Glucose Metabolism in Chronically Sleep-Deprived Individuals.

Authors:  Apichart So-Ngern; Naricha Chirakalwasan; Sunee Saetung; Suwannee Chanprasertyothin; Ammarin Thakkinstian; Sirimon Reutrakul
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

9.  Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

10.  Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

Authors:  Deborah A Elder; Jessica G Woo; David A D'Alessio
Journal:  Pediatr Diabetes       Date:  2010-08       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.